All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
Bluesky
Twitter
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

London Summit explores AI-powered clinical trials for neurodegenerative diseases

By

Dementia Researcher

2h ago· 22 min readenNews

Summary

The DEMON Network and LifeArc hosted the London Summit on AI Enabled Trials in Neurodegeneration on 27 May 2026, bringing together researchers, clinicians, data scientists, and trial specialists. The summit explored how artificial intelligence could transform the design, delivery, and evaluation of clinical trials for neurodegenerative diseases. Dementia Researcher recorded talks from the event covering AI applications in trial recruitment, patient selection, and remote trial enablement.

Source

bskyLondon Summit explores AI-powered clinical trials for neurodegenerative diseasesdementiaresearcher.nihr.ac.uk

Key quotes

· 3 pulled
The DEMON Network and LifeArc hosted the London Summit on AI Enabled Trials in Neurodegeneration, bringing together researchers, clinicians, data scientists and trial specialists to explore how artificial intelligence could reshape the way neurodegeneration trials are designed, delivered and evaluated.
Dementia Researcher attended the event to record a selection of talks for those unable to join in person.
Together, these presentations offer a wide ranging look at how AI might support clinical trials, from improving recruitment and patient selection to enabling remote trials.
Snippet from the RSS feed
LifeArc and the DEMON Network share talks from the London Summit on AI Enabled Trials in Neurodegeneration, covering AI, trial design and remote trials.

You might also wanna read

NeurIPS 2024: Reinforcement Learning Emerges as Next AI Frontier, Google Surges, and Conference Culture Shifts

The article covers the 2024 NeurIPS conference in San Diego, highlighting three main trends: reinforcement learning (RL) emerging as the nex

The Verge·6mo ago

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design

The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse

drugtargetreview.com·4mo ago

Google DeepMind CEO claims goal of "solving all disease" through AI drug discovery

This special early edition of The Verge's Optimizer newsletter, tied to Google I/O coverage, contextualizes a bold claim made by Google Deep

The Verge·29d ago

AI Lab Leaders Exchange Criticism at Davos World Economic Forum

AI lab leaders from Google DeepMind, OpenAI, and Anthropic engaged in public criticism and competitive jabs at the World Economic Forum in D

The Verge·4mo ago

Neuroscience Challenges AI Optimism: Are Large Language Models a Path to True Intelligence?

The article examines the ambitious claims by tech leaders like Mark Zuckerberg, Dario Amodei, and Sam Altman about achieving superintelligen

The Verge·6mo ago

Boston Dynamics and Google DeepMind Partner to Integrate AI with Humanoid Robots for Industrial Applications

Boston Dynamics and Google DeepMind have announced a strategic partnership at CES 2026 to integrate Google's Gemini Robotics AI foundation m

bostondynamics.com·5mo ago